Immunotherapy: Keeping breast cancer in check
Nature Reviews Cancer 17, 454 (2017).
doi:10.1038/nrc.2017.55
Author: Liesbet Lieben
Nolan et al. show that triple-negative breast cancers with BRCA1 mutations are immunogenic and susceptible to treatment with a combination of two checkpoint inhibitors and chemotherapy.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Liesbet Lieben Tags: Research Highlight Source Type: research